Table of Contents

company-logo

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Immunovant Dividend Announcement

• Immunovant does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Immunovant dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Immunovant Dividend History

Immunovant Dividend Yield

Immunovant current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Immunovant stock? Use our calculator to estimate your expected dividend yield:

Immunovant Financial Ratios

P/E ratio-13.01
PEG ratio-0.13
P/B ratio9.36
ROE-56.40%
Payout ratio0.00%
Current ratio7.61
Quick ratio7.61
Cash Ratio7.10

Immunovant Dividend FAQ

Does Immunovant stock pay dividends?
Immunovant does not currently pay dividends to its shareholders.
Has Immunovant ever paid a dividend?
No, Immunovant has no a history of paying dividends to its shareholders. Immunovant is not known for its dividend payments.
Why doesn't Immunovant pay dividends?
There are several potential reasons why Immunovant would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Immunovant ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Immunovant has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Immunovant a dividend aristocrat?
Immunovant is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Immunovant a dividend king?
Immunovant is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Immunovant a dividend stock?
No, Immunovant is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Immunovant stocks?
To buy Immunovant you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Immunovant stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.